Pelvic exenteration (PE) is one of the most drastic operations in surgical oncology, associated with severe morbidity and mortality. The objective of our study was to review our experience of PE in terms of surgical characteristics, complications, and overall survival. All patients who had PE surgery between January 1999 and December 2015 were identified. Patients with verified distant metastatic disease were excluded. Patients with advanced pelvic tumors experiencing incapacitating postradiation severe damages were included. The following parameters were recorded: age, sex, indication for surgery, tumor histology, type of exenteration, urinary tract and colon reconstruction methods, operative time, blood transfusion, intensive care unit admissions, length of hospital stay and readmissions, and characteristics of perioperative morbidity and mortality. A total of 25 patients were submitted to PE by our surgical team. Most of the patients suffered from cervical cancer followed by bowel cancer. There was no perioperative mortality. Early postoperative complications ensued in 56% of the patients. Most complications involved the urinary system. Five years survival was estimated at 38%. Most patients (n = 9, 36%) died due to their primary disease, 5 (20%) died because of complications following operation, and 2 (8%) died because they denied oral feeding, which was associated with depression. Patients with a variety of malignancies can benefit from PE. Meticulous surgical technique, perioperative care, counseling, and nutritional support play an important role.
Pelvic exenteration Pelvic malignancy Cervical cancer Gynecologic cancer Colon cancer
This is a preview of subscription content, log in to check access.
Compliance with Ethical Standards
Local Ethics Committee approval was applied for but was not deemed necessary by our hospital committee due to the retrospective nature of our study.
Conflict of Interest
The authors declare that they have no conflict of interest.
Brunschwig A (1948) Complete excision of pelvic viscera for advanced carcinoma; a one-stage abdominoperineal operation with end colostomy and bilateral ureteral implantation into the colon above the colostomy. Cancer 1:177–183CrossRefGoogle Scholar
Iavazzo C, Vorgias G, Akrivos T (2008) Laparoscopic pelvic exenteration: a new option in the surgical treatment of locally advanced and recurrent cervical carcinoma. Bratisl Lek Listy 109:467–469PubMedGoogle Scholar
Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240:205–213CrossRefGoogle Scholar
Bannura GC, Barrera AE, Cumsille MA, Contreras JP, Melo CL, Soto DC, Mansilla JE (2006) Posterior pelvic exenteration for primary rectal cancer. Color Dis 8:309–313CrossRefGoogle Scholar
Ike H, Shimada H, Yamaguchi S, Ichikawa Y, Fujii S, Ohki S (2003) Outcome of total pelvic exenteration for primary rectal cancer. Dis Colon Rectum 46:474–480CrossRefGoogle Scholar
Ghouti L, Pereira P, Filleron T, Humeau M, Guimbaud R, Selves J, Carrere N (2010) Pelvic exenterations for specific extraluminal recurrences in the era of total mesorectal excision: is there still a chance for cure?: a single-center review of patients with extraluminal pelvic recurrence for rectal cancer from March 2004 to November 2010. Am J Surg 209:352–362. https://doi.org/10.1016/j.amjsurg.2014.01.008CrossRefGoogle Scholar
Crowe PJ, Temple WJ, Lopez MJ, Ketcham AS (1999) Pelvic exenteration for advanced pelvic malignancy. Semin Surg Oncol 17:152–160CrossRefGoogle Scholar
Park JY, Choi HJ, Jeong SY, Chung J, Park JK, Park SY (2007) The role of pelvic exenteration and reconstruction for treatment of advanced or recurrent gynecologic malignancies: Analysis of risk factors predicting recurrence and survival. J Surg Oncol 96:560–568CrossRefGoogle Scholar
Goldberg GL, Sukumvanich P, Einstein MH, Smith HO, Anderson PS, Fields AL (2006) Total pelvic exenteration: the Albert Einstein College of Medicine/Montefiore Medical Center Experience (1987 to 2003). Gynecol Oncol 101:261–268CrossRefGoogle Scholar
Wydra D, Emerich J, Sawicki S, Ciach K, Marciniak A (2006) Major complications following exenteration in cases of pelvic malignancy: a 10-year experience. World J Gastroenterol 12:1115–1119CrossRefGoogle Scholar